Vbi Vaccines Incis A Biopharmaceutical Company Based In Cambridgemassachusettswith Research Facilities In Ottawaontariofounded In 1965 And Rebranded In 2016Vbi Focuses On Immunologyaiming To Prevent And Treat Diseases Through Innovative Vaccine Technologies The Company Develops Vaccine Candidates Using Advanced Platformsincluding The Enveloped Virus Like Particleevlptechnologywhich Mimics Natural Viruses To Stimulate Immune Responsesanother Key Platform Is The Mrna Launched Evlpmletechnologyenhancing Vaccine Efficacyvbi S Product Lineup Includes Sci B Vaca Hepatitis B Vaccineand Several Candidates In Developmentsuch As Vbi 2601 For Chronic Hbv Infection And Vbi 1901A Glioblastoma Vaccine In Clinical Studies Vbi Vaccines Is Publicly Traded On Nasdaq Under The Ticker Vbivthe Company Is Committed To Advancing Its Research And Development Effortsfocusing On Significant Infectious Diseases And Cancersand Is Actively Pursuing Innovative Solutions In The Biopharmaceutical Field
No conferences found for this company.
| Company Name | Vbi Vaccines Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
